Increased expression of T cell activation markers (CD25, CD26, CD40L and CD69) in atherectomy specimens of patients with unstable angina and acute myocardial infarction

Atherosclerosis

Volumn 168, Issue 1, 2003, Pages 73-80

  Hosono, Mitsuharu ^a   De Boer, Onno J ^a   Van Der Wal, Allard C ^a   Van Der Loos, Chris M ^a   Teeling, Peter ^a   Piek, Jan J ^a   Ueda, Makiko ^b   Becker, Anton E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; CD40L; Inflammation; T cell activation; T cells

Indexed keywords

CD3 ANTIGEN; CD40 LIGAND; CD69 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 2 RECEPTOR;

ACUTE HEART INFARCTION; ANTIGEN EXPRESSION; ARTICLE; ATHERECTOMY; BLOOD VESSEL INJURY; CELL ASSAY; CELL STIMULATION; CELLULAR PARAMETERS; CHRONIC DISEASE; DISEASE SEVERITY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE ACTIVATION; UNSTABLE ANGINA PECTORIS;

EID: 0038065618     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(03)00024-8     Document Type: Article

References (30)

1. van der Wal A.C., Becker A.E. Atherosclerotic plaque rupture - pathologic basis of plaque stability and instability. Cardiovasc. Res. 41:1999;334-344.
2. de Boer O.J., van der Wal A.C., Houtkamp M.A., Ossewaarde J.M., Teeling P., Becker A.E. Unstable atherosclerotic plaques contain T cells that respond to Chlamydia pneumoniae. Cardiovasc. Res. 48:2000;402-408.
3. Frostegård J., Ulfgren A.K., Nyberg P., Hedin U., Swedenborg J., Andersson U., et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 145:1999;33-43.
4. van der Wal A.C., Piek J.J., de Boer O.J., Koch K.T., Teeling P., van der Loos C.M., et al. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart. 80:1998;14-18.
5. Campeau L. Grading of angina pectoris. Circulation. 54:1976;522-523.
6. Braunwald E. Unstable angina pectoris: a classification. Circulation. 80:1989;410-414.
7. Seitzer U., Scheel-Toellner D., Mattern T., Haas H., Flad H.D., Gerdes J. Staining pattern of seven monoclonal anti-CD26 antibodies in leprosy: implications for the use of CD26 as a surrogate marker of a human Th1-like reaction. Virchows Arch. 432:1998;343-347.
8. Graf D., Müller S., Korthäuer U., van Kooten C., Weise C., Kroczek R. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25:1995;1749-1754.
9. van der Loos C.M. Immunoenzyme Multiple Staining Methods. Royal Microscopical Society Handbook no. 45. 1999;BIOS Scientific Publishers, Oxford.
10. Hansson G.K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:1989;169-175.
11. Neri Serneri G.G., Prisco D., Martini F., Gori A.M., Brunelli T., Poggesi L., et al. Acute T-cell activation is detectable in unstable angina. Circulation. 95:1997;1806-1812.
12. + T-lymphocytes and their interleukin 2 receptor expression in vitro. Biochem. J. 330:1998;659-666.
13. de Boer O.J., Hirsch F., van der Wal A.C., van der Loos C.M., Das P.K., Becker A.E. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. Atherosclerosis. 133:1997;227-234.
14. Cerdan C., Martin Y., Courcoul M., Brailly H., Mawas C., Birg F., et al. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J. Immunol. 149:1992;2255-2261.
15. Kneitz B., Herrmann T., Yonehara S., Schimpl A. Normal clonal expansion but impaired FAS-mediated cell death and energy induction in interleukin-2 deficient mice. Eur. J. Immunol. 25:1995;2572-2577.
16. Leung D.T., Morefield S., Willerford D.M. Regulation of lymphoid homeostasis by IL-2 receptor signals in vivo. J. Immunol. 164:2000;3527-3534.
17. Poulton T.A., Gallagher A., Potts R.C., Beck J.S. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation. Immunology. 64:1988;419-425.
18. Ehara S., Ueda M., Naruko T., Haze K., Itoh A., Otsuka M., et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation. 103:2001;1955-1960.
19. Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol. Today. 15:1994;180-184.
20. Schönbeck U., Libby P. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58:2001;4-43.
21. Castle B.E., Kishimoto K., Stearns C., Brown M.L., Kehry M.R. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151:1993;1777-1788.
22. de Boer O.J., van der Wal A.C., Teeling P., Becker A.E. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc. Res. 41:1999;443-449.
23. Mach F., Schönbeck U., Sukhova G.K., Bourcier T., Bonnefoy J.Y., Pober P.S., et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA. 94:1997;1931-1936.
24. Szabolcs M.J., Cannon P.J., Thienel U., Chen R., Michler R.E., Chess L., et al. Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery disease. Virchows Arch. 437:2000;149-159.
25. López-Cabrera M., Santis A.G., Fernández-Ruiz E., Blacher R., Esch F., Sanchez-Mateos P., et al. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal transmitting receptors. J. Exp. Med. 178:1993;537-547.
26. Caligiuri G., Paulsson G., Nicoletti A., Maseri A., Hansson G.K. Evidence for antigen-driven T-cell response in unstable angina. Circulation. 102:2000;1114-1119.
27. Nakajima T., Schulte S., Warrington K.J., Kopecky S.L., Frye R.L., Goronzy J.J., et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation. 105:2002;570-575.
28. Zhu J., Quyyumi A.A., Norman J.E., Csako G., Waclawiw M.A., Shearer G.M., et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am. J. Cardiol. 85:2000;140-146.
29. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 92:1995;3893-3897.
30. Houtkamp M.A., van der Wal A.C., de Boer O.J., van der Loos C.M., de Boer P.A.J., Moorman A.F.M., et al. Interleukin-15 expression in atherosclerotic plaques: an alternative pathway for T-cell activation in atherosclerosis? Arterioscler. Thromb. Vas. Biol. 21:2001;1208-1213.